Literature DB >> 4023558

Human fascioliasis in Cajamarca/Peru. II. Humoral antibody response and antigenaemia.

J Knobloch.   

Abstract

Four immunoassays (IgG ELISA, indirect haemagglutination = IHA, IgM ELISA and antigen ELISA) for determination of humoral antibody and of circulating antigen, respectively, were applied to sera of 45 Peruvian fascioliasis patients who were identified by demonstration of Fasciola eggs in faeces. All of the sera were reactive by at least one of the assays. Sensitivity rates were 0.98 for IgG ELISA, 0.56 for IHA, 0.51 for IgM ELISA and 0.20 for antigen ELISA. Among those 34 patients who were followed up after praziquantel therapy there was a different pattern of immunoassay results between patients who stopped excreting eggs after therapy and those who continued to pass eggs. Cure was indicated by disappearance of both IgM antibody and antigen levels during three months after treatment, whereas persistence of infection corresponded to new or re-occurrence of IgM antibody and/or circulating antigen during the period of observation. Since there was no apparent relation of immunoassay results to therapy, it is presumed that the Peruvian patients did not respond to praziquantel at all.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4023558

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  11 in total

Review 1.  Serodiagnosis of parasitic diseases.

Authors:  S E Maddison
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  Immunodiagnosis of human fascioliasis by an enzyme-linked immunosorbent assay (ELISA) and a micro-ELISA.

Authors:  S Carnevale; M I Rodríguez; G Santillán; J H Labbé; M G Cabrera; E J Bellegarde; J N Velásquez; J E Trgovcic; E A Guarnera
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

3.  Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis.

Authors:  Olgary Figueroa-Santiago; Bonnibel Delgado; Ana M Espino
Journal:  Diagn Microbiol Infect Dis       Date:  2011-07       Impact factor: 2.803

4.  Detection of circulating excretory secretory antigens in human fascioliasis by sandwich enzyme-linked immunosorbent assay.

Authors:  A M Espino; R Marcet; C M Finlay
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

5.  Direct, immunological and molecular techniques for a fasciolosis survey in a rural area of San Luis, Argentina.

Authors:  Silvana Carnevale; Marta Graciela Cabrera; Marcela Alejandra Cucher; Cecilia Alicia di Risio; Jorge Bruno Malandrini; Laura Kamenetzky; Marcio Alazraqui; Cristina Beatriz Etchart; María Laura Pantano; Jorge Néstor Velásquez
Journal:  J Parasit Dis       Date:  2012-09-28

Review 6.  Studies on helminthosis at the Centre for Tropical Veterinary Medicine (CTVM).

Authors:  L J Harrison; J A Hammond; M M Sewell
Journal:  Trop Anim Health Prod       Date:  1996-02       Impact factor: 1.559

7.  Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infections.

Authors:  A Marcilla; J E De la Rubia; J Sotillo; D Bernal; C Carmona; Z Villavicencio; D Acosta; J Tort; F J Bornay; J G Esteban; R Toledo
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

8.  Sandwich enzyme-linked immunosorbent assay for detection of excretory secretory antigens in humans with fascioliasis.

Authors:  A M Espino; C M Finlay
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

9.  Ectopic fascioliasis mimicking a colon tumor.

Authors:  Ozer Makay; Baris Gurcu; Cemil Caliskan; Deniz Nart; Muge Tuncyurek; Mustafa Korkut
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

10.  Use of the PCR in a Combined Methodological Approach for the Study of Human Fascioliasis in an Endemic Area.

Authors:  Silvana Carnevale; Jorge Bruno Malandrini; María Laura Pantano; Mirna Sawicki; Laura Kamenetzky; Claudia Cecilia Soria; Jorge Néstor Velásquez
Journal:  Acta Parasitol       Date:  2020-10-28       Impact factor: 1.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.